Clinical trials
Phase 1 Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,388 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 15 |
| 2001 | 20 |
| 2002 | 8 |
| 2003 | 25 |
| 2004 | 42 |
| 2005 | 52 |
| 2006 | 72 |
| 2007 | 86 |
| 2008 | 67 |
| 2009 | 58 |
| 2010 | 63 |
| 2011 | 81 |
| 2012 | 67 |
| 2013 | 53 |
| 2014 | 74 |
| 2015 | 64 |
| 2016 | 58 |
| 2017 | 57 |
| 2018 | 61 |
| 2019 | 42 |
| 2020 | 57 |
| 2021 | 46 |
| 2022 | 39 |
| 2023 | 42 |
| 2024 | 28 |
| 2025 | 36 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 903 |
| Terminated | 247 |
| Recruiting | 91 |
| Active, not recruiting | 63 |
| Withdrawn | 37 |
| Unknown status | 25 |
| Suspended | 11 |
| Not yet recruiting | 8 |
| Enrolling by invitation | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 88 |
| GlaxoSmithKline | 57 |
| AbbVie | 56 |
| Pfizer | 44 |
| Bristol-Myers Squibb | 32 |
| Eli Lilly and Company | 32 |
| Novartis Pharmaceuticals | 31 |
| Bayer | 26 |
| M.D. Anderson Cancer Center | 25 |
| AstraZeneca | 24 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 1,388 |
| Neoplasm Metastasis | 176 |
| Carcinoma, Non-Small-Cell Lung | 161 |
| Breast Neoplasms | 111 |
| Colorectal Neoplasms | 95 |
| Melanoma | 94 |
| Lymphoma | 88 |
| Lung Neoplasms | 80 |
| Ovarian Neoplasms | 76 |
| Pancreatic Neoplasms | 71 |
Trials
Showing 1 to 25 of 1,388. Each trial links to its page on Pharma Observatory.
1,288 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.